ArticleClinical & translational immunology2020

p.P476S mutation of RBPJL inhibits the efficacy of anti-PD-1 therapy in oesophageal squamous cell carcinoma by blunting T-cell responses.

Lei Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.